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Background
In the past years, we have witnessed unprecedented atten-
tion for the study of epigenetic alterations in the context
of a variety of complex disorders, including autoimmune
diseases [1]. This is in part due to the observation that
genetics is insufficient to entirely explain the predisposi-
tion to their pathogenesis. The environmental influence is
well illustrated by the existence of partial concordance for
susceptibility to disease in monozygotic twins. In connec-
tion with this epigenetic mechanisms regulate gene
expression and are sensitive to external stimuli, bridging
the gap between environmental and genetic factors. There
is now considerable evidence of the existence of epigenetic
alterations, particularly DNA methylation alterations, in
diseases like systemic lupus erythematosus or rheumatoid
arthritis [1]. Most of the studies were initially performed
by using candidate-gene approaches, although the increas-
ing availability of high-throughput methods is providing
better methods for the screening of epigenetic alterations
in these diseases [2].
Materials and methods
We have used different methylation bead arrays to profile
the DNA methylation status of CpG sites in both samples
o b t a i n e df r o mp a t i e n t sf r o md i f f e r e n ta u t o i m m u n ed i s e a s e s
and normal individuals as well as different experimental
models that allow to explore conditions where the immune
tolerance is lost. Following bioinformatics analysis, we indi-
vidually validate relevant genes by bisulfite pyrosequencing
and check their expression levels by quantitative RT-PCR.
The potential role of different chromatin factors in these
changes is then explored by using experimental models
where these factors can be overexpressed or knocked-
down. Also, their direct association at specific genomic
sites can be investigated by using chromatin immunopreci-
pitation assays.
Results
High-throughput and candidate sequence analysis of
DNA methylation in samples from different autoimmune
diseases show the existence of alterations associated with
these diseases. We have also identified DNA methylation
changes in association with several factors associated
with autoimmune disease like infection with Epstein
Barr-virus of B cells. Most of the changes observed occur
in the direction towards hypomethylation associated with
gene upregulation.
Conclusions
Our findings are providing potentially relevant DNA
methylation markers for the clinical managements of dif-
ferent autoimmune diseases and also support the notion
that epigenetic alterations may be critical in the pathogen-
esis of autoimmune disease.
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